Home › Colon Cancer › Pennsylvania › Pittsburgh
Pag-aaral pangklinika para sa Colon Cancer sa Pittsburgh, PA
9 pag-aaral para sa Colon Cancer ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Pittsburgh (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Distance-Based Exercise to Preserve Function and Prevent Disability
Nagre-recruit
- UPMC Hillman Cancer Center, Pittsburgh
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Nagre-recruitPhase 3
- UPMC Hillman Cancer Center ( Site 2024), Pittsburgh
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Nagre-recruitPhase 1/2
- Allegheny Health Network, Pittsburgh
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Nagre-recruitPhase 3
- Allegheny General Hospital Cancer Institute, Pittsburgh
- Hillman Cancer Center, Pittsburgh
A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
Nagre-recruitPhase 2
- Allegheny General Hospital, Pittsburgh
- Magee-Womens Hospital of UPMC, Pittsburgh
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Nagre-recruit
- UPMC-Presbyterian Hospital, Pittsburgh
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Nagre-recruitPhase 2/3
- Allegheny General Hospital, Pittsburgh
- UPMC-Presbyterian Hospital, Pittsburgh
- UPMC-Saint Margaret, Pittsburgh
- at 18 pa
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Nagre-recruitPhase 1
- University of Pittsburg Medical Center (UPCM), Pittsburgh
Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
Nagre-recruitPhase 2
- UPMC Hillman Cancer Center, Pittsburgh
Pag-aaral para sa Colon Cancer sa ibang lungsod
- Boston, MA22 pag-aaral
- New York City, NY22 pag-aaral
- Houston, TX20 pag-aaral
- Los Angeles, CA16 pag-aaral
- Nashville, TN16 pag-aaral
- St. Louis, MO15 pag-aaral
- Arlington, VA15 pag-aaral
- Chicago, IL14 pag-aaral
- San Antonio, TX14 pag-aaral
- Baldwin Park, CA14 pag-aaral
- Baltimore, MD13 pag-aaral
- Tampa, FL13 pag-aaral
Iba pang pag-aaral sa Pittsburgh
- Non-Small Cell Lung Cancer48 pag-aaral
- Kanser (lahat ng uri)41 pag-aaral
- Kanser sa Suso39 pag-aaral
- Colorectal Cancer32 pag-aaral
- Metastatic Cancer31 pag-aaral
- Melanoma31 pag-aaral
- Kanser sa Ovary30 pag-aaral
- Kanser ng Endometrium23 pag-aaral
- Kanser sa Prostate23 pag-aaral
- Kanser sa Baga23 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg22 pag-aaral
- Stroke22 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.